UPDATED May 01, 2024
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARGX | €350.80 | 0.3% | -1.2% | €20.8b | €439.32 | PS17.5x | E56.1% | n/a | Pharmaceuticals & Biotech | ||
UCB | €124.55 | 3.1% | 47.1% | €23.6b | €125.49 | PE68.9x | E26.3% | 1.1% | Pharmaceuticals & Biotech | ||
DIE | €203.20 | -1.4% | 19.2% | €10.8b | €253.00 | PE21.6x | E18.6% | 1.8% | Retail |